Progyny, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Progyny, Inc. (PGNY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.76 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-02-27
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-12-31 was 364.21K shares.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.76M shares, a 29.36% decline from fiscal 2024.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.49M shares, a 27.60% increase from fiscal 2023.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.95M shares, a 70.88% decline from fiscal 2022.
- Progyny, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 6.71M shares, a 26.85% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|
| 2025-12-31 | 1.76M shares 10-K · filed 2026-02-27 | ||
| 2024-12-31 | 2.49M shares 10-K · filed 2025-03-03 | ||
| 2023-12-31 | 1.95M shares 10-K · filed 2024-02-29 | ||
| 2022-12-31 | 6.71M shares 10-K · filed 2023-03-01 | ||
| 2021-12-31 | 5.29M shares 10-K · filed 2022-03-01 | ||
| 2020-12-31 | 1.38M shares 10-K · filed 2021-03-01 | ||
| 2019-12-31 | 364.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 7.07M shares 10-K · filed 2020-03-10 | |
| 2019-09-30 | 6.71M shares 10-Q · filed 2019-12-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |